Welcome to the Investor Relations section of CareFusion’s website. Here, we provide access to a variety of shareholder materials, including financial and stock information, corporate governance resources and access to our presentations and events. We are committed to providing you with convenient access to these resources, and if you need additional information, please contact us.
You can also sign up to receive email alerts when new company information is available by going to CareFusion’s Email Alerts page.
To receive printed copies of CareFusion investor materials by mail, you can submit an on-line request here. You may also send an email to email@example.com with your contact information and material request.
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMined™ services for data mining surveillance, and V. Mueller® and Snowden-Pencer® surgical instruments.
|There are currently no events scheduled.|
View all of CareFusion’s Events & Presentations.
Annual Meeting and Proxy Information
Learn more about CareFusion Annual Meeting of Stockholders and access our Annual Report and Proxy Statement here.
Access more detailed stock information.
|05/09/13||CareFusion Reports Third Quarter Fiscal 2013 Results|
|- Revenue of $901 million in line with company expectations
- GAAP operating margins of 15 percent increased to 22.3 percent on an adjusted basis
- GAAP diluted earnings per share (EPS) from continuing operations totaled $0.37, including the impact of a previously disclosed reserve for an expected government settlement
- Adjusted diluted EPS from continuing operations increased 5 percent to $0.59
SAN DIEGO, May 9, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global m... |
|04/25/13||CareFusion Reaches Agreement In Principle On Previously Disclosed Matter With Federal Government|
|SAN DIEGO, April 25, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced an agreement in principle to resolve previously disclosed government investigations related to prior sales and marketing practices for its ChloraPrep® skin preparation product and its relationships with health care professionals.
The company expects to pay the government approximately $41 million to resolve the allegations. CareFusion will record the charge in... |
|04/15/13||CareFusion to Report Third Quarter Fiscal 2013 Results on May 9|
|SAN DIEGO, April 15, 2013 /PRNewswire/ -- CareFusion Corporation (NYSE: CFN) today announced plans to release third quarter fiscal 2013 results on Thursday, May 9, following the close of trading on the New York Stock Exchange.
The company will host a conference call on May 9 at 2 p.m. PDT (5 p.m. EDT) to discuss the results for its third quarter fiscal 2013, ended on March 31, 2013. To access the call, visit the Investors page at www.carefusion.com. Log on at least 15 minutes before the ca... |
|03/06/13||CareFusion Announces Proposed Offering Of $300 Million Senior Notes|
|SAN DIEGO, March 6, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN) today announced a private offering of $300 million aggregate principal amount of senior notes, the net proceeds of which the company intends to use for general corporate purposes.
The notes will be senior unsecured obligations of the company, offered solely to qualified institutional buyers in the United States in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain ... |
Read all of
CareFusion’s financial news releases.
Read CareFusion’s news releases.
Cautions Concerning Forward-Looking Statements: This website contains statements that are forward-looking and consequently are subject to risks and uncertainties. Examples of these statements include statements regarding our financial guidance, our expectations regarding hospital capital spending, our expected standup costs and other costs related to the separation from Cardinal Health and other statements regarding matters that are not historical facts. You should be aware that certain factors may affect us in the future and could cause actual results to differ materially from those expressed in these forward-looking statements. Such factors include the risk factors set forth in our Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement to reflect subsequent events or circumstances.
Print Page : Email Page : : Sign up for news : Contact Information : Tear Sheet